(Q36803777)

16 August 2017

1 reference

title

Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization (English)

1 reference

16 August 2017

0 references

1 reference

3

Arlene A Forastiere

1 reference

16 August 2017

Lawrence Kleinberg

1

1 reference

16 August 2017

Michael K Gibson

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

1 May 2007

1 reference

Nature Clinical Practice Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

282-294

1 reference

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Epidemiology of esophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

The epidemic of esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Cisplatin and bleomycin in the treatment of esophageal carcinoma: A final report

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Multimodality approach to treatment of carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Nonoperative therapy for squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Oxygen, hyper- and hypobaric. Current and possible future trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Hypoxic Stress Proteins: Survival of the Fittest

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Tumor microenvironmental physiology and its implications for radiation oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Variations in several responses of HeLa cells to x-irradiation during the division cycle

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

X-RAY AND ULTRAVIOLET SENSITIVITY OF SYNCHRONIZED CHINESE HAMSTER CELLS AT VARIOUS STAGES OF THE CELL CYCLE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiation and the cell cycle, revisited

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Biologic basis for combining drugs with radiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Thymidylate synthase and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

The mechanism of action of radiosensitization of conventional chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiosensitizing nucleosides

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Effects of 5-fluorouracil on cell cycle arrest and toxicity induced by X-irradiation in normal mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

5-Fluorouracil radiation sensitization--a brief review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Cisplatin and radiation: interaction probabilities and therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Irradiation enhances cellular uptake of carboplatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Carboplatin as a potentiator of radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Carboplatin Enhances the Production and Persistence of Radiation-Induced DNA Single-Strand Breaks

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Apoptosis-modulating agents in combination with radiotherapy-current status and outlook

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

DNA intercalating agents as adjuvants in radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Engaging the vascular component of the tumor response

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0796

7 January 2021

Identifiers

DOI

10.1038/NCPONC0796

1 reference

16 August 2017

1 reference